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Wild-type Sendai virus expresses three proteins containing the N-terminal half of the P protein open reading frame due to
mRNA editing; a full-length P protein (ca. 70% of the total), a V protein with the N-terminal half fused to a Cys-rich Zn21-binding
domain (ca. 25% of the total), and a W protein representing the N-terminal half alone (ca. 5% of the total). To examine the role
of these proteins in the virus life cycle, we have prepared recombinant viruses in which the normal V mRNA expresses a W
protein (V-stop; 70% P, 30% W), one which cannot edit its P gene mRNA (D6A; 100% P), and one which overedits its mRNA
like parainfluenza virus type 3 (swap/8; 20–40% P, 30% V, 30% W). All these viruses were readily recovered and grew to similar
titers in eggs, and except for the P gene products, cell lines individually infected with these viruses accumulated similar
amounts of viral macromolecules. The relative competitive advantage of each virus was determined by multiple cycle
coinfections of eggs and found to be rSeV-Vstop 5 rSeV-wt @ rSeV-D6A . rSeV-swap/8. On the other hand, rSeV-swap/8
underwent multiple cycles of replication in C57Bl/6 mouse lungs and was highly virulent for these animals, whereas
rSeV-D6A was avirulent in mice and this infection was quickly cleared. Remarkably, rSeV-Vstop appeared to be more virulent
for inbred C57Bl/6 mice than rSeV-wt, but was partially attenuated in infections of outbred ICR mice. Thus, the expression
of either the V or the W proteins is sufficient for multiple cycles of infection and pathogenesis in C57Bl/6 mice, whereas W
can only partially substitute for V for pathogenesis in ICR mice. © 1998 Academic Press
Sendai virus (SeV) is a prototypic paramyxovirus, con-
taining a nonsegmented negative-strand RNA genome.
SeV particles are composed of a helical nucleocapsid
core containing the genome RNA of 15,384 nt assembled
with 2564 copies of the N (formerly NP) protein, to which
ca. 300 copies of the P phosphoprotein and ca. 50 copies
of the L (large) protein are bound. This core is sur-
rounded by a lipid envelope containing the F and HN
transmembrane glycoproteins and the M (matrix) protein.
Paramyxovirus genomes serve as templates for both
monocistronic mRNAs and for a full-length complemen-
tary antigenome strand, the intermediate in genome
replication. The synthesis of both genomes and anti-
genomes is coupled to their assembly, and they are
consequently found only as nucleocapsids assembled
with N protein (reviewed in Lamb and Kolakofsky, 1996).
Six mRNAs (in the order N, P, M, F, HN, and L) are
transcribed from the N:RNA genome template by the P–L
polymerase. All these viral mRNAs except the P gene
mRNA express a single primary translation product from
a single ORF. The paramyxovirus P gene mRNAs, in
contrast, generally contain alternate ORFs which overlap
the N-terminus as well as the middle region of the P
protein ORF and express several proteins. For SeV, e.g.,
the C protein ORF overlaps the N-terminal region of P
ORF and is accessed via ribosomal choice during trans-
lational initiation (Curran and Kolakofsky, 1997; cf. Fig. 1).
The highly conserved, cysteine-rich V ORF which over-
laps the middle of the P ORF, on the other hand, is
accessed by a mechanism involving transcriptional
choice, referred to as cotranscriptional mRNA editing
(Thomas et al., 1988; Vidal et al., 1990).
The Paramyxovirinae are currently organized in three
genera, the paramyxovirus genus [including SeV, human
parainfluenza virus type 1 (hPIV1), and human and bo-
vine PIV3 (h/bPIV3)], the morbilliviruses (e.g., measles
and the distemper viruses), and the rubulaviruses (e.g.,
mumps and SV5). All these viral P genes, with the nota-
ble exception of hPIV1, contain an AnGn purine run at the
start of the internal, overlapping V ORF (Thomas et al.,
1988; Cattaneo et al., 1989). The alternate base-pairing
possibilities of this ‘‘slippery sequence’’ (including G:U
bonds) (Vidal et al., 1990) are used to synthesize trans-
frame proteins (i.e., proteins whose N- and C-terminal
portions are encoded by separate ORFs, like the HIV
gag-pol polyprotein (Kollmus et al., 1996). This situation
is analogous to ribosomal frameshifting which forms this
HIV protein, except that for paramyxovirus mRNA editing,
the alternate base pairing occurs during mRNA synthe-
sis, via pseudo-templated transcription (Jacques and Ko-
lakofsky, 1991). As a result, mRNAs with expanded G
runs are transcribed from these genes in addition to
those which are faithful copies of their templates, and
the number of G insertions which occurs for each virus
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group mirrors their requirements to switch between the
in-frame and out-of-frame ORFs (reviewed in Kolakofsky
et al., 1993). For the morbilliviruses and SeV, which re-
quire a 11G insertion to access the V ORF from the
genome-encoded P ORF (Fig. 1), a single G is added as
the predominant insertional event, generating a V mRNA
coding for the trans-frame V protein. Two Gs, however,
are also inserted at a much reduced frequency, and this
leads to a protein called W, which is essentially the
N-terminal part of the P protein up to the editing site (this
downstream ORF is quickly closed by a stop codon; Fig.
1). For h/bPIV3 which contain an additional (D) ORF at
this position, one to six G residues are inserted at
roughly equal frequencies, to accommodate the expres-
sion of all three overlapping ORFs (P, V, and D) (Pelet et
al., 1991; Galinski et al., 1992). For hPIV1, the one excep-
tion, mRNA editing does not occur, and the remnants of
the V ORF are closed by 9–11 stop codons as well
(Matsuoka et al., 1991; Rochat et al., 1992).
The paramyxovirus P proteins are modular proteins,
and this diversity of G insertion patterns is used to
shuffle domains via mRNA editing (Curran et al., 1991a).
The best studied of these domains lie in the C-terminal
40% of the SeV protein. When SeV mRNA synthesis is
studied independent of genome replication, only those
regions downstream of the G insertion site (codon 317)
are required, namely, the predicted coiled-coil responsi-
ble for the protein’s trimerization, the stable L protein-
binding site, and the N:RNA (template)-binding site (Cur-
ran, 1996, and Refs. therein) (Fig. 1). This C-terminal 40%
of the SeV P protein thus represents the minimal poly-
merase cofactor. The coiled-coil region and the putative
N:RNA-binding site (a predicted triple a-helical bundle),
moreover, are conserved at the same relative positions
for all the Paramyxovirinae (Curran et al., 1995a); i.e., the
RNA polymerase module is always located in the C-
terminal half of P. In the paramyxovirus genus and the
morbilliviruses, mRNA editing therefore serves to detach
the polymerase module from the N-terminal half of the P
protein and to either replace it with a cysteine-rich Zn21-
binding domain (or the D ORF in the case of h/bPIV3) or
to simply truncate the protein at this point. To date, only
a single functional domain, for chaperoning unas-
sembled N protein during the nascent chain assembly
step of genome replication (aa 33–41, Fig. 1), has been
mapped to the N-terminal 60% of the SeV P protein
(Curran et al., 1995b). Its location is consistent with the
finding that overexpression of V or W can inhibit genome
replication, but not mRNA synthesis (Curran et al., 1991a).
The only other known feature of the N-terminal part of
SeV P is that it contains the site(s) at which phosphates
are added in a stable fashion (Byrappa et al., 1995, 1996).
As the only notable property of the V and W proteins
was their ability to repress genome replication, and this
property resided in their common N-terminal 317 resi-
dues and not the Zn21-binding domain of V, it seemed
reasonable that other functions for these proteins, and
specifically for V, would be found. One such function(s)
has recently been suggested for SeV by Kato et al.
(1997a), who found that a recombinant SeV (rSeV) which
could not express its V or W proteins was highly atten-
uated for mice. Since this virus replicated well in cell
culture and eggs, they suggested that V encodes a lux-
ury function, required for pathogenesis. This paper re-
ports the characterization of further rSeV with altered P
gene expression, which attempts to distinguish whether
this luxury function is shared by both V and W or is
specific to the Zn21-binding domain of V.
FIG. 1. The reading frame organization of the SeV P gene. The
ORFs expressed as protein are shown as horizontal boxes, with
their functional domains indicated (see text). The site (codon 316/
317) at which G residues are added during mRNA synthesis is
indicated by the 1G bracket above the nucleotide sequence, and
the consequences of the 1G and 2G insertions on the shuffling of the
alternate C-terminal domains are shown below. The nucleotide
sequence differences between the wild-type and the swap/8, D6A,
and V-stop mutants is shown above the wild-type sequence, and
their consequences on the P protein amino acid sequence are
indicated by bracketed lowercase sequences in italics for substitu-
tions and a box for the deletion. Numbers refer to amino acid
positions. Stop codons are represented by asterisks.
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RESULTS
Preparation of rSeV with altered P, V, and W gene
ORF expression
rSeV-Vstop contains a single base substitution relative
to rSeV-wt (Delenda et al., 1997) which closes the V ORF
just downstream of the mRNA-editing site and converts
this translation product into one (called W*) which differs
from the normal W protein only by the substitution of its
C-terminal Gly-Ala amino acid sequence with Gly-His-
Arg-Arg (Fig. 1). A further consequence of this mutation is
that Glu320 of the P protein is replaced by Asp320. rSeV-
Vstop was found to edit its P gene mRNA normally, yield-
ing ca. 70% unedited P protein mRNA, 25% V protein
mRNA (11G), and 5% W protein mRNA (12G). However,
extracts of the rSeV-Vstop-infected cells are found to ac-
cumulate only the P protein and the W/W* proteins as
expected, the latter as a single band in proportion to their
combined mRNA abundance, as W and W* comigrate
(Fig. 2). The absence of V protein and its replacement by
W* had no noticeable effect on the growth of this virus in
eggs or cell culture (Delenda et al., 1997), but its infection
of mice, a natural host, was not initially examined.
Two more rSeV with altered P gene expression have
also been prepared. In rSeV-D6A, the run of six ad-
enosines preceding the GGG of the editing site have
been deleted, with the resulting deletion of Lys314 and
Lys315 from the P ORF (Fig. 1). From other work, we know
that the entire deletion of residues 145–324 does not
affect the activity of P in viral RNA synthesis in reconsti-
tuted intracellular systems, and so the P of rSeV-D6A
would be expected to be similarly active in RNA synthe-
sis. The A6 run, however, is an essential component of
the cis-acting sequence which controls mRNA editing
(Jacques et al., 1994). Cells infected with rSeV-D6A do not
expand the GGG run during mRNA synthesis (data not
shown) and accumulate only P protein (Fig. 2). The other
virus, rSeV-swap/8, in contrast, contains the essential 59
A6G3 core of the cis-acting sequence, but the eight ad-
jacent upstream nucleotides (59 GACTCAAC) have been
replaced with the sequence 59 AGGGAATT which is
found upstream of the bPIV3 P gene A6G4-editing site.
This replacement results in this rSeV editing its P gene
mRNA similarly to that of bPIV3; i.e., ca. 50% of the mRNA
have G residues inserted, and one to six Gs are now
added at roughly equal frequency (Hausmann et al.,
manuscript in preparation). Because of this ‘‘overediting’’
of the P gene mRNA, cells infected with rSeV-swap/8
accumulate V proteins roughly similarly to SeV-wt-in-
fected cells, but they also contain approximately six
times more W protein and consequently less P protein
than SeV-wt-infected cells (Fig 2). This lesser amount of
P protein has only a small effect on the rate of virus
replication as measured by the accumulation of N pro-
tein (only the 20-h time point is shown in Fig. 2B, but the
same proportions are found at 12 and 36 h.p.i., and
similar results were found in infections of A549 cells
(data not shown)). The eight-base substitution also re-
places the tripeptide Asp-Ser-Thr313 with Arg-Glu-Leu313
(Fig. 1). rSeV-swap/8 also differs from the other rSeV in
containing the N gene of strain H rather than strain Z, as
an electrophoretic marker.
The above alterations in P protein structure were
found not to affect the activity of these proteins in viral
RNA synthesis in reconstituted intracellular systems, nor
their ability to rescue infectious virus from DNA (data not
shown). As it is not possible to express the V protein
independent of W (at least by altering the resident P
gene), this completes the range of our possibilities. In
general, the P, V, and W proteins accumulated in the
various rSeV-infected cells in proportion to the abun-
dance of their mRNAs. Relative to rSeV-wt which ex-
presses its in-frame and trans-frame P proteins in the
ratio of 70 P, 25 V, and 5 W, rSeV-Vstop expresses them in
the ratio of 70 P, no V, and 30 W/W*; rSeV-swap/8 in the
ratio of roughly 20–40 P (depending on the cell line
infected), 30 V, and 30 W; and rSeV-D6A expresses only
P (Fig. 2).
Characterization of rSeV with altered P gene
ORF expression in cell culture and
embryonated chicken eggs
rSeV-D6A and rSeV-swap/8 were both recovered from
DNA as readily as rSeV-wt and grew to similar titers as
rSeV-wt or rSeV-Vstop (ca. 5 3 108 PFU/ml) in eggs. When
BHK (hamster), MDCK (canine), LLC-MK2 (monkey), or
A549 (human) cells in culture were infected with 10
PFU/cell of each of these altered P gene rSeV, these
cells were found to accumulate viral genomes, anti-
FIG. 2. P gene expression of the various rSeV. BHK cells were
infected with a 10 PFU/cell of the various viruses listed above. Cyto-
plasmic extracts were prepared at 20 h.p.i., and equal amounts of these
extracts were examined by immunoblotting with (A) rabbit polyclonal
antisera to the P protein and (B) a monoclonal antibody to the N protein.
h, host band which cross-reacts with the anti-P serum, which serves as
an internal control for the amount of cytoplasmic sample.
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genomes, and N mRNA similarly to rSeV-wt-infected
cells (as determined by primer extension). They also
accumulated similar amounts of viral proteins intracellu-
larly (except for the P gene products noted above). We
were thus unable to differentiate these viruses with al-
tered P gene expression by comparing their individual
infections of cell culture. The cell lines we examined,
however, liberate noninfectious virions with uncleaved
fusion protein (Fo). Hence, relative advantages during
multiple rounds of replication, a stronger test of virus
fitness (Holland et al., 1992), are not seen here.
Multiple rounds of replication do occur in embryo-
nated chicken eggs where blood clotting factor X cleaves
the virion Fo and restores virus infectivity (Gotoh et al.,
1990). When eggs are coinfected with equal amounts
(105 PFU) of our reference strains SeVH and SeVZ, and
the progeny stock (diluted 1/1000) is used to reinfect
eggs, the resulting allantoic fluid still contains equal
amounts of these two viruses. This is not unexpected, as
SeVH and SeVZ represent the same virus maintained in
eggs in different laboratories for many years and have
remained 99% identical in nucleotide sequence. The
SeVH and SeVZ N proteins can, however, be distin-
guished by their electrophoretic mobility (due to a point
mutation). The ability of these reference strains to com-
pete equally with each other in eggs is indicated by the
same relative amounts of NH and NZ in the second
passage allantoic fluid as in the initial infecting mix
(Garcin et al., 1995). Similarly, when rSeVZ (recovered
from the full-length cDNA of SeVZ) and rSeVZ-NH (whose
NZ gene was replaced with NH) are used to coinfect
eggs, these two rSeV also appear to compete equally
with each other.
The competitive advantage (or disadvantage) of each
rSeV with altered P gene expression relative to each
other and to rSeV-NH or rSeV (NZ) was thus determined
by coinfection of eggs, except for the rSeV-Vstop vs rSeV-
D6A combination which both express NZ. As shown in
Fig. 3, rSeV-Vstop competed equally with rSeV-NH (Vstop 1
WT), whereas rSeV-D6A was mostly eliminated, and
rSeV-swap/8 was completely eliminated (gel not shown)
by rSeV-wt after two passages in eggs. Consistent with
these results, rSeV-swap/8 was completely eliminated by
competition with rSeV-Vstop, and rSeV-D6A had a clear
but modest advantage over rSeV-swap/8. The relative
competitive advantages (or fitness) of these viruses for
replication in eggs is thus rSeV-Vstop 5 rSeV-wt 5
rSeV-NH . rSeV-D6A . rSeV-swap/8. These results sug-
gest that the W protein can replace V for replication in
eggs as well as in cell culture. On the other hand,
rSeV-D6A which cannot express either V or W, and
whose P protein is deleted for Lys315 and Lys316, has a
clear disadvantage relative to rSeV-Vstop and rSeV-wt.
Similarly, rSeV-swap/8, which essentially overexpresses
W, and which underexpresses a P protein containing a
tripeptide substitution, has an even stronger disadvan-
tage. At least for rSeV-swap/8, the disadvantage would
appear to stem from the altered expression of the in-
frame and trans-frame proteins rather than the mutations
in P, since rSeV-swap/8 grows normally in the mouse
respiratory epithelium, in which multiple rounds of repli-
cation also occur (see below). The disadvantage of rSeV-
D6A relative to rSeV-Vstop and rSeV-wt may also be due to
the lack of the V and W proteins rather than the Lys-
Lys316 deletion of its P protein. However, further rSeV will
need to be examined to be more certain of this.
Infection of mice
Specific pathogen-free C57Bl/6 mice were inoculated
intranasally with 5 3 105 PFU of each rSeV with altered
P gene expression as well as rSeV-NH as a virulent virus
control (rSeV-NH and rSeV are both highly virulent for
C57Bl/6 mice). The mice were weighed daily as a gen-
eral indicator of their health (Fig. 4), as loss of body
weight correlates well with disease progression (Kiyo-
FIG. 3. Competition between the various viruses during coinfections
of eggs. The various viruses and combinations of viruses listed above
were passaged twice in eggs as described in the text. The viruses
present in 50 ml of the second passage allantoic fluid were pelleted
through 25% glycerol in TNE, and the pellet was taken up in SDS
sample buffer and electrophoresed on a 10% SDS polyacrylamide gel.
The gel was stained with Coomassie brilliant blue and then scanned.
The proportions of NH and NZ in the samples were determined with the
One-D Scan software and are shown in the table above.
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tani et al., 1990). Groups of three mice were sacrificed at
various times postinfection, and their lungs were re-
moved. One lobe was fixed in formol–saline for histolog-
ical examination, and total RNA was extracted from the
remaining lobes. Except for rSeV-D6A which did not
induce detectable weight loss, the other viruses were
highly virulent by this criterion and by histological exam-
ination of the lungs. These virus-infected mice all
steadily lost weight and either died or were killed in
extremis by day 8 (Fig. 4). rSeV-NH- and rSeV-swap/8-
infected mice lost weight similarly, starting on day 3,
whereas rSeV-Vstop-infected mice lost weight more
quickly.
The lung lesions in mice infected with rSeV-NH (wt),
rSeV-Vstop, or rSeV-swap/8 were similar to those de-
scribed previously (Robinson et al., 1968), and were char-
acterized, early in infection, by hypertrophy of the bron-
chial epithelium, cell debris and polymorphonuclear leu-
kocytes in the bronchial lumen, and peribronchiolar and
perivascular infiltrations on mononuclear cells and poly-
morphonuclear leukocytes (Figs. 5a and 5b). In these
mice, degenerative changes in the bronchiolar epithe-
lium were seen from ca. day 6 (Fig. 5c). Although there
was a relative absence of viral RNA or virus in mice
infected with rSeV-D6A, there was nevertheless an ex-
tensive histopathological reaction to this infection, which
was present at day 2 and had resolved by day 10. The
lesions in the rSeV-D6A-infected mice were character-
ized by hypertrophy of the bronchial epithelium, perivas-
cular and peribronchiolar accumulations of mononuclear
cells (Figs. 5d and 5e), and interstitial alveolitis. In con-
trast to mice infected with rSeV-NH (wt), rSeV-Vstop, or
rSeV-swap/8, there was little necrosis of bronchiolar ep-
ithelial cells and few neutrophils in the lungs of rSeV-
D6A-infected mice. These results suggest that the rapid
weight loss in mice infected with the former rSeV may be
related to the pulmonary neutrophil response.
The relative amounts of the viral genomes, anti-
genomes, and N mRNAs present in the lungs were de-
termined by primer extension (Garcin et al., 1997) (Fig. 6).
Consistent with the weight loss curves, all the infected
mice except those infected with rSeV-D6A accumulated
viral RNAs steadily over 4 days, and the rSeV-Vstop-in-
fected mice accumulated the viral RNAs slightly more
quickly than the others. RNA levels peaked at days 4–6
and then declined, and the ratios and levels of genomes,
antigenomes, and N mRNAs were roughly similar for the
three virulent viruses. The amounts of genomes and
antigenomes shown for day 0 are those determined for
the entire virus inoculums. Given that only a small frac-
tion of these virus particles entered the lungs and led to
infected centers, the large increase in the amounts of
viral RNAs in the lungs over days 4–6 reflects the multi-
ple rounds of replication which had occurred. The lungs
of rSeV-D6A-infected mice, in contrast, did not accumu-
late viral RNAs. It is difficult to determine the levels of
infectious virus in the lungs directly by plaque titration,
as some of these viruses form turbid plaques which are
hard to score. However, the relative amounts of virus in
these tissues was determined by inoculation of the lung
homogenates into eggs, followed by Coomassie blue
staining of the virus pelleted from the allantoic fluid, and
these levels were found to parallel those of the intracel-
lular RNAs (data not shown). The relevant regions of the
viral genomes recovered from the lungs were amplified
by RT/PCR and sequenced. In all cases, the mutations
introduced were found to be stable (data not shown).
The virulence of rSeV-Vstop was also examined in out-
bred ICR (or CD-1) mice, in comparison to C57Bl/6 mice
(see Discussion). Mice were inoculated intranasally with
5 3 105 PFU of the viruses as before. Body weight loss
was very similar in infections of the two mouse strains
for the first 2–3 days (Fig. 7). From this time on, however,
the infections followed different courses. The weight of
the ICR mice remained relatively constant until day 8,
although some of these mice (two in five) died or were
killed in extremis at this time, whereas the C57Bl/6 mice
continued to steadily lose weight as before (Fig 4) and all
these mice were either dead or were killed in extremis by
day 7. In summary, the response to rSeV-Vstop infection
was found to vary with the mouse strain. In C57Bl/6 mice,
lethal pneumonia due to multiple cycles of virus replica-
FIG. 4. Weight loss of the various virus infected C57Bl/6 mice.
Groups of 6-week-old C57Bl/6 mice weighing ca. 18 g were infected
with 5 3 105 PFU of the various viruses listed. They were weighed daily
as a general indicator of their health, and their loss of weight (in grams)
is plotted. Each point represents the average of at least three mice.
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FIG. 5. Histological changes in the lungs of mice infected with Sendai viruses with altered P, V, and W expression. Hypertrophy of the bronchiolar
epithelium, bronchiolar exudate containing desquamated epithelial cells and polymorphonuclear leukocytes and peribronchiolar lymphoid cell
infiltration in mice infected with (a) rSeV-wt at day 4 (bar, 50 mm) or (b) rSeV-Vstop at day 2 (bar, 30 mm). (c) The degenerative changes in the bronchiolar
epithelium of mice infected with rSeV-Vstop at day 6 (bar, 30 mm). Hypertrophy of the bronchiolar epithelium and peribronchiolar lymphoid cell
infiltration, with few polymorphonuclear leukocytes, in rSeV-D6A-infected mice at (d) day 4 (bar, 30 mm) and (e) day 8 (bar, 50 mm). Hematoxylin and
eosin staining.
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tion in the mouse respiratory tract occurs under condi-
tions where either V (rSeV-wt) or W (rSeV-Vstop) is the
predominant trans-frame P gene product, and their com-
bined overexpression (rSeV-swap/8) does not attenuate
virulence for mice. In outbred ICR mice, however, infec-
tion with rSeVZ-Vstop leads to a slightly milder disease
which does not always end in lethal pneumonia.
DISCUSSION
Three rSeV with altered P, V, and W protein expression
have been prepared, to examine the role that the acces-
sory V and W proteins might play in infections of mice.
Because the mutations in the P gene we introduced to
effect these altered expressions also mutate the P pro-
tein (an essential subunit of the viral polymerase), the
relative abilities of these rSeV to compete with each
other and wild-type virus in multiple cycle infections of
eggs was determined. In this test, rSeV-swap/8, which
accumulates less of the essential P protein due to en-
hanced expression of the inhibitory V and W proteins,
and whose P protein contains three nonconservative aa
substitutions, was found to have the strongest competi-
tive disadvantage. rSeV-Vstop, on the other hand, which
simply converts V into W* and contains a single conser-
vative aa substitution in P, was found to have the small-
est competitive disadvantage. In infections of C57Bl/6
mice, however, both rSeV-swap/8 and rSeV-Vstop under-
went multiple cycles of replication and were highly viru-
lent like rSeV-wt, whereas rSeV-D6A (or rSeVedit-minus),
which had an intermediate competitive disadvantage in
eggs, was quickly cleared from the mouse lungs and did
not cause serious disease. Kato et al. (1997a) have re-
cently described another rSeVedit-minus which cannot ex-
press its V or W proteins (like rSeV-D6A, but whose P
protein sequence is wild type) which was also highly
attenuated in infections of ICR mice, even though it
replicated well in eggs and in cell culture. The ability of
these viruses to undergo multiple cycles of replication in
the mouse respiratory tract clearly does not correlate
with their ability to replicate in eggs (compare Figs 3 and
5), presumably because of the differences in the immune
systems of these organisms.
An important question now is whether the inability of
rSeVedit-minus to successfully infect mice is due solely to the
absence of V with its unique, Zn21-binding domain (Liston
and Breidis, 1994; Paterson et al., 1995), or whether this
avirulence is also due to the absence of W. In the former
case, the compensatory expression of W should not sub-
stitute for V, and mice infected with rSeV-Vstop (like those
infected with rSeVedit-minus) should suffer little or no disease.
In the latter case, the compensatory expression of W would
in part substitute for V, and therefore, rSeV-Vstop would be
more virulent than rSeVedit-minus in mice. To this end, a stop
codon has been introduced into the V ORF by Kato et al.
(1997b) which converts V into a protein which differs from W
only by the replacement of the C-terminal Gly-Ala with
Gly-His-Arg, and we have carried out the same operation
one codon downstream, such that our W-like protein termi-
nates Gly-His-Arg-Arg. Kato et al. (1997b) have recently
found that their rSeV-Vstop (called VDC) is mostly attenuated
for 3-week-old ICR mice; VDC had a LD50 of 2 3 10
7 CIU vs
1.3 3 108 for edit-minus and 8 3 105 for wild type. VDC was
FIG. 6. Presence of viral RNAs in the infected lungs. Mice infected as described in the text and Fig. 4 were sacrificed at various times postinfection.
Their lungs were removed and the total RNA in these tissues was extracted by Dounce homogenization and Trizol (Gibco-BRL). The relative amounts
of viral genomes (A), antigenomes (B), and N mRNAs (C) in these samples were determined by primer extension (Methods and Materials).
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thus only slightly more virulent than their rSeVedit-minus in
these animals, indicating that the attenuation was mainly
due to the absence of the V protein. Our mouse infections
are not strictly comparable to those of Kato et al., as we
have used 5-week-old ICR mice (whose weight was
matched to the 7-week-old C57Bl/6 mice) and we have not
determined LD50. However, we have since obtained VDC
from Kato et al. and have compared its infection of ICR and
C57Bl/6 mice (both weighing ca. 20 g) alongside that of
rSeV-Vstop (Fig. 7). By the criterion of body weight loss, our
results are basically in agreement with those of Kato et al.
ICR mice infected with either rSeV-Vstop or VDC mostly
stopped losing body weight by day 3 although some deaths
occurred on days 5 to 8, whereas C57Bl/6 mice infected
with the same viruses lost body weight continuously until
the experiment had to be terminated on day 7 of the infec-
tion. Thus, whereas W can only partly replace V for patho-
genesis in 5-week-old ICR mice, it can almost completely
replace V for pathogenesis in 7-week-old C57Bl/6 mice
(Figs. 4 and 6). The remaining differences in our results and
those of Kato et al. [that VDC is mostly attenuated in 3-week-
old (10 g) and only slightly attenuated in 5-week-old (20 g)
ICR mice] may be due the different ages of ICR mice
infected, genetic differences in the English and Japanese
outbred ICR mice, or differences in the titers of SeV in the
inoculum.
It now appears that the accessory V, W, and C proteins,
all initially characterized as negative effectors of viral
RNA synthesis in reconstituted intracellular systems
(Curran et al., 1991a, 1992) are required for multiple
rounds of infection in mice. It is unlikely that these
essentially nonstructural P gene products play a role in
virus entry or release, as rSeVedit-minus and rSeV-CMVC
[which contains a mutant C protein (Garcin et al., 1997)]
grow very well in cell culture, and virus titers in the
mouse lungs increase normally for the first day (Kato et
al., 1997; Garcin et al., 1997). Rather, Sendai viruses
which cannot express either a V/W protein or express a
mutant C protein appear to be particularly sensitive to
the antiviral defenses of the mouse. The containment of
virus burden in these animal infections is apparent as
early as day 2 (e.g., Fig. 5), and because of this timing,
some aspect(s) of innate immunity is presumably playing
a role here (Kato et al., 1997a). Two aspects of innate
immunity which could be important are natural killer cells
and interferons, which are thought to recognize general
signatures of viral infections (Nathan, 1995). Protection of
mice from lethal SeV pneumonia by low doses of anti-
CD3 antibodies has been found to occur through activa-
tion of NK cells (Kast et al., 1990), and induction of
interferon in mouse lungs is a very early response to SeV
infection (Robinson et al., 1968).
The genetic determinants which control mouse sus-
ceptibility to lethal SeV pneumonia are known to be
complex, and there is evidence that some of these loci
may be expressed through NK cell activity (Brownstein
and Winkler, 1987). It is possible that the ability of W to
completely replace V for pathogenesis in C57Bl/6 but not
ICR mice is due to the genetic backgrounds of these
animals, as C57Bl/6 are homozygous (haplotype b) for
MHC class I, whereas the ICR mice are outbred and are
known to be polymorphic at this locus (Katoh et al., 1990).
The MHC class I locus may be of particular importance
here, as whether NK cells lyse (or fail to lyse) target cells
depends on inhibitory receptors (NKRs) that recognize
MHC class I molecules (Yokahama and Seaman, 1993;
Re´nard et al., 1997; Ljunggren and Karre, 1990). Given
that the repertoire of MHC class I and NKR alleles of
each mouse strain would be different, this could explain
why W can completely replace V for apparently circum-
venting host defense mechanisms in C57Bl/6, but not in
ICR mice. However, both C57Bl/6 and ICR mice infected
with either rSeV-Vstop or VDC lose weight similarly for the
first 2–3 days, a time when the differences in innate
immunity might be expected to be more apparent. It is
thus possible that V and W operate at other levels of the
host defense systems or even through their inhibitory
effects on viral RNA synthesis or on cell biology such as
membrane permeability. If we assume that ICR mice are
inherently more resistant to lethal SeV infection due to a
stronger general immunity to this pathogen (which in-
FIG. 7. Weight loss of rSeV-Vstop and VDC-infected C57BL/6 and ICR
mice. Groups of 5 to 6-week old C57BL/6 mice and 4 to 5-week old ICR
mice both weighing ca. 20 g, were infected with 5 x 105 PFU of either
rSeV-Vstop or VDC or mock infected, as indicated. They were weighed
daily as a general indicator of their health, and their loss of weight (in
grams) is plotted. Each point represents the average of at least three
mice.
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cludes interferons, other cytokines, NK cells, etc.), ICR
mice may more efficiently recognize and eliminate SeV-
infected cells than C57Bl/6 mice. Both V and W presum-
ably act in allowing the infection to avoid the immune
response, but V would be the stronger of the two. In ICR
mice, the expression of W alone circumvents the immune
response less efficiently, and host defense mechanisms
attenuate the effects of the infection to some extent. In
C57Bl/6 mice with a weaker ability to recognize and
eliminate SeV-infected cells, W expression alone is suf-
ficient to completely replace V in circumventing the im-
mune response.
Our finding that the SeV W protein functions to allow
multiple rounds of virus replication in some mice may
also resolve an enigma. More than a dozen paramyxo-
virus P genes have now been examined, and curiously,
all but hPIV1 and hPIV3 express a V protein. These two
human viruses are members of the paramyxovirus ge-
nus, together with SeV (or murine PIV1) and bPIV3. We
assume that the four viruses of this genus are all suc-
cessful pathogens to have survived until now and that
this requires some mechanism to avoid the immunity of
the host. Given that these viruses are so closely related,
it seems reasonable that they employ homologous gene
products for this task. Human PIV3 does not express a V
protein, but it expresses both a W protein and a D protein
(another C-terminally extended W protein) via mRNA ed-
iting, either of which could function in modulating immu-
nity. The enigma is that human PIV1 does not edit its P
gene mRNA as it does not have a cis-acting editing
signal, and the remnants of the 68 residue long V ORF
are closed by an extraordinary 9 to 11 stop codons in
various isolates (Rochat et al., 1992). However, it is not
impossible that hPIV1 produces a W-like protein by an-
other mechanism, such as ribosomal frameshifting to
one of these stop codons, or even proteolysis, which
would serve a similar function.
METHODS AND MATERIALS
Cell cultures and viruses
LLC-MK2, BHK, MDCK, and A549 cell lines were
grown in MEM supplemented with 5% fetal calf serum.
Wild-type and recombinant Sendai virus stocks were
prepared in the allantoic cavity of 9-day-old embryonated
chicken eggs and harvested after 3 days at 33°C.
Construction of the cDNAs and generation of viruses
The Vstop cDNA has been previously cloned into pFL3
and pGem-P/Cstop (Delenda et al., 1997). The D6A cDNA
was cloned into the same plasmids; a PCR was per-
formed with pFL3 DNA using 59-2882GATGACTCGAAT-
TCTTGAGC2863-39 (superscript numbers refer to genome
map positions starting from the 59 end of the antigenome
or 39 end of the genome) and 59-CTAGAGGATCCCCGG-
GTCTAGAGAGCGACTCAACGGGCATAGGAGAG2802-39
as primers, digested by XbaI/EcoRI and cloned into the
same sites of pGem-P/Cstop. The recombinant SmaI frag-
ment was then introduced into pFL3 to generate pFL3-
D6A shuttle vector. Generation of recombinant viruses
was carried out as described previously (Delenda et al.,
1997). Briefly, vTF7-3 vaccinia-infected A549 cells were
transfected with pGem-L, pGem-N, pGem-P, and wild
type (pFL3) or recombinant full-length plasmids (pFL3-
Vstop or pFL3-D6A). Twenty-four hours later, ara-C at 100
mg/ml was added to inhibit vaccinia virus replication, and
24 h after that, cells were removed from the dishes and
injected into the allantoic cavity of embryonated chicken
eggs.
The swap/8 cDNA was generated by PCR using
59-2768GACTCTAGAGGGAATTAAAAAAGGG2792-39 and
59-3017GGGCACGTCTTGCAAACA2900-39 as primers; the
amplified product was then digested by XbaI/EcoRI and
introduced into the same sites of pGem-PHA and pN/
PXho/M plasmid previously described in Garcin et al.
(1995). The recovery system for the swap/8 virus was
recently described (Garcin et al., 1997); it is based on the
recombination in vaccinia/T7-infected cells (Fuerst et al.,
1986) of pN/PXho/M and FL3-D1 shuttle vectors. Of
course, pGem-L, pGem-N, and pGem-P plasmids were
added. The same final strategy was carried out for the
swap/8 virus.
The presence of viruses in the allantoic fluids was de-
termined by pelleting viruses at 14,000 rpm through a TNE-
25% glycerol cushion. Pelleted viruses were then lysed in
sample buffer, the proteins were separated by 10% SDS–
PAGE and stained with Coomassie brilliant blue.
Immunoblotting
Immunoblotting of cytoplasmic extracts was per-
formed with the primary antibodies mAb N877 (Orvell
and Grandien, 1982) and a rabbit polyclonal antibody
PSDS (Curran et al., 1991a). The secondary antibodies
used were peroxidase-conjugated goat anti-mouse or
anti-rabbit IgG (F(ab9)2 fragment specific). The immobi-
lized proteins were detected by light-enhanced chemilu-
minescence according to the manufacturer’s instructions
(ECL, Amersham).
Primer extension
Total RNAs extracted with Trizol (Gibco-BRL) from one
lung in each infected mouse were analyzed by primer
extension using MMLV reverse transcriptase (Gibco-
BRL) and 50,000 cpm of 32P-59-primers. These are 59-
126CGGCCATCGTGAACTTTGGC107-39 for antigenomes
and N mRNAs detection and 59-15270GAAGCTCCGCGG-
TACC15286-39 for genomes detection. Total RNAs were
combined with the specific radioactive probes and 10 mg
of glycogen as carrier and ethanol precipitated. The
pellets were washed with 70% ethanol, dissolved in 16 ml
of 0.2 M NaCl, boiled for 2 min, and annealed for 10 min
at 42°C. Each reaction (50 ml) was then adjusted to
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contain 50 mM Tris–HCl, pH 8.0, 8 mM MgCl2, 10 mM
DTT, 0.5 mM dNTPs, plus 200 U of MMLV RTase and
incubated for 1 h at 42°C. The reaction was then ethanol
precipitated, dissolved in 10 ml formamide buffer, and
boiled, and one-third of the sample was separated on a
8% sequencing gel.
Infection of mice
Five to six-week-old (female) specific pathogen-free
(SPF) C57Bl/6 mice or 4- to 5-week-old SPF ICR mice,
both ca. 20 g in weight, were obtained from Charles River
(UK) and infected intranasally with 5 3 105 PFU of viruses
under sodium pentobarbitone anesthesia. The mice
were maintained in an SPF environment throughout the
duration of the study and observed for symptoms and
weighed daily. Three mice per assay were sacrificed at 2,
4, 6, 8, or 10 days after virus inoculation. Infected lungs
were recovered; the presence in one lobe of viruses,
RNAs, and proteins was determined after subsequent
homogenization (for viruses) and further Trizol (Gibco-
BRL) extraction for RNAs and proteins. Histological lung
examinations were performed on the remaining lobe.
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